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Abstract:  This study used real-time PCR assays to screen small sample volumes for a 
comprehensive range of 35 respiratory pathogens. Initial thermocycling was limited to 20 
cycles to avoid competition for reagents, followed by a secondary real-time multiplex PCR. 
Supplementary semi-nested human metapneumovirus and picornavirus PCR assays were 
required to complete the acute respiratory pathogen profile. Potential pathogens were 
detected in 85 (70%) of pernasal aspirates collected from 121 children with acute 
respiratory symptoms. Multiple pathogens were detected in 29 (24%) of those samples. The 
tandem multiplex real-time PCR was an efficient method for the rapid detection of multiple 
pathogens. 
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1. Introduction 
In recent years, improved nucleic acid amplification and detection technology has facilitated the 
identification of pathogens that had previously proved difficult or impossible to detect using traditional 
culture or immunofluorescent techniques. The increased use of molecular methods has also resulted in 
the discovery of novel respiratory pathogens including the human coronaviruses NL63 [1], HKU1[2] 
and the SARS coronavirus [3], human metapneumovirus [4], human bocavirus [5] and two human 
polyomaviruses, KI [6] and WU [7]. Despite these advances, there remain a significant proportion of 
respiratory disease episodes for which a pathogenic agent can not be identified [8, 9]. 
The aim of this study was to modify real-time PCR assays to facilitate the rapid screening of 
respiratory samples for a comprehensive range of viral and bacterial pathogens. Standard PCR assays 
require extraction of RNA and DNA with simultaneous removal of inhibitors of the PCR process from 
the sample. Multiple extracts from each sample have been required to set up a comprehensive range of 
PCR assays for respiratory pathogens, and the sample volume available may be insufficient for all of 
the required tests. Also, previous attempts at multiplex PCR have been limited by competition between 
different amplification reactions and by the limited number of fluorescent probes able to be monitored 
in the same tube. A multiplex tandem PCR assay which utilized a two step PCR system consisting of a 
limited multiplex PCR followed by a single target PCR has been reported [10]. Our study further 
modified that procedure to include real-time PCR with specific probes in the second step of the assay. 
It comprised two first round enrichment PCR assays (A and B) containing 27 and 7 primer pairs 
respectively, and the second step real-time PCR assays containing 1 - 3 primer pairs and specific 
Taqman probes. The assay detects several adenovirus genotypes, Bordetella species, human bocavirus, 
Chlamydophila pneumoniae and psittaci, coronaviruses OC43, 229E, HKU1 and NL63, Haemophilus 
influenzae, influenza viruses A, B and C, Legionella longbeachae and pneumophila,  Moraxella 
catarrhalis, Mycoplasma pneumoniae, parainfluenzaviruses 1 – 4, Pneumocystis jirovecii, KI and WU 
polyomaviruses, respiratory syncytial virus types A and B, Streptococcus pyogenes and pneumoniae. 
Supplementary semi-nested human metapneumovirus and picornavirus PCR assays are required to 
complete the acute respiratory pathogen profile. 
This technique facilitates the investigation of a comprehensive range of respiratory pathogens from 
a single nucleic acid extract and a single reverse transcription reaction. In addition, the ability to 
amplify multiple targets efficiently aids in the detection of mixed infections. 
2. Results and Discussion 
2.1. Relative Sensitivity of the tandem multiplex real-time assay 
The sensitivity of the tandem multiplex real-time PCR assay was greater than or equal to that of 
singleplex real-time or traditional nested PCR assays for the majority of the agents investigated (Table 
1). Exceptions included the detection of adenovirus and influenza virus C in the tandem multiplex real-
time assay, which were 100-fold and 10-fold less sensitive respectively than the established nested 
PCR assay. While the adenovirus real-time assay performed similarly in the multiplex and singleplex 
assays, both had lower sensitivity than the traditional nested assay, suggesting the need to redesign the 
primers and probes used in the real-time assays. This differed from the influenza virus C assay, where Viruses 2009, 1  
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the lower sensitivity appeared to be related to the multiplex format, and may therefore necessitate 
further fine-tuning of the assay.  
Table 1. Relative sensitivity of the multiplex tandem real-time PCR compared to single 
real-time and nested PCR in-house assays. 
Target DNA/RNA 
Highest 10 fold dilution detected 
Multiplex Tandem 
real time PCR 
Singleplex real 
time PCR 
Nested PCR 
[11-20] 
Adenovirus (Group B)  10
-4 10
-4 10
-6 
Bocavirus 10
-7 10
-7 NA
b 
Bordetella pertussis 
Bordetella holmesii 
Bordetella parapertussis  
Bordetella bronchoseptica 
10
-5 
10
-8 
10
-8 
10
-8 
10
-5 
10
-8 
10
-7 
10
-8 
10
-5 
10
-8 
NA 
NA 
Chlamydophila pneumoniae  10
-4 10
-5 10
-4 
Chlamydophila psittaci  10
-6 10
-6 10
-5 
Coronavirus 229E  10
-8 10
-7 10
-7 
Coronavirus HKU1  10
-2 10
-2 NA 
Coronavirus NL63  10
-2 10
-3 NA 
Coronavirus OC43  10
-8 10
-9 10
-8 
Haemophilus influenzae  10
-5 10
-5 NA 
Influenza virus A H1
a 10
-6 (Matrix 10
-6) 10
-6 (Matrix 10
-6) 10
-6 
Influenza virus A H3
a 10
-8 (Matrix 10
-6) 10
-7 (Matrix 10
-6) 10
-6 
Influenza virus B  10
-6 10
-7 10
-6 
Influenza virus C  10
-4 10
-5 10
-5 
Legionella longbeachae  10
-4 10
-4 10
-3 
Legionella pneumophila  10
-5 10
-4 10
-3 
Moraxella catarrhalis  10
-5 10
-5 NA 
Mycoplasma pneumoniae  10
-5 10
-5 10
-5 
Parainfluenzavirus 1 
Parainfluenzavirus 2 
Parainfluenzavirus 3 
Parainfluenzavirus 4A 
Parainfluenzavirus 4B 
10
-8 
10
-6 
10
-6 
10
-6 
10
-3 
10
-7 
10
-6 
10
-5 
10
-6 
10
-3 
10
-8 
10
-6 
10
-5 
NA 
NA 
Pneumocystis jirovecii  10
-3 10
-2 10
-2 
Polyomavirus KI 
Polyomavirus WU 
10
-1 
10
-5 
10
-1
10
-3 
NA 
NA 
RSV A 
RSV B 
10
-7 
10
-4 
10
-7 
10
-4 
10
-7 
10
-4 
Streptococcus pyogenes  10
-6 10
-6 NA 
Streptococcus pneumoniae  10
-3 10
-3 NA 
Equine herpesvirus 4
c 10
-5 10
-5 NA 
MS-2 RNA coliphage
c 10
-8 10
-7 NA 
a Separate assays for the HA and matrix gene sequences. Matrix assay results in brackets; 
b NA = 
Test not available in this laboratory; 
c Viruses added to samples to monitor successful nucleic acid 
extraction, cDNA production and PCR inhibitor removal. 
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2.2. Clinical samples tested in the tandem multiplex real-time assay 
Pernasal aspirates from 121 hospitalized children aged between 3 days and 16 years (mean = 20 
months old, median = 7 months old) collected from July to September 2006 were tested in the tandem 
multiplex real-time PCR assay and the results are presented in Table 2. Respiratory pathogens were 
detected in 85 samples (71%) and multiple pathogens were detected in 29 of those 85 samples (34%). 
This detection rate excludes samples where Moraxella catarrhalis and/or Streptococcus pneumoniae 
were detected, as the significance of the detection of these agents in pernasal aspirates using PCR 
amplification techniques remains doubtful [21-23]. Further studies are under way to gather more 
information about asymptomatic nasopharyngeal carriage rates for viral and bacterial pathogens. 
 Respiratory syncytial virus (RSV) was the most common pathogen and was detected in 41 samples. 
For 21 of those samples, at least one, and up to three other respiratory agents, including human 
rhinovirus, human bocavirus, KI and WU polyomaviruses, human coronaviruses, parainfluenzavirus 
and group A streptococcus, were also detected. Rhinoviruses were the next most commonly detected 
(37 samples) and again, multiple agents were commonly detected (17 samples) and included RSV, 
human coronaviruses, human bocavirus, parainfluenzavirus, adenovirus, KI and WU polyomaviruses 
and group A streptococcus. Other pathogens detected included influenza virus type B, human 
metapneumovirus and Pneumocystis jirovecii. 
The tandem multiplex real-time assay failed to detect pathogens that had previously been detected 
on initial routine testing in six samples. The agents were rhinovirus (2), parainfluenza type 2, 
parainfluenza type 3, human metapneumovirus and influenza B. Repeat testing of samples indicated 
that for the two parainfluenzavirus failures there had been a slight reduction in nucleic acid extraction 
sensitivity due to the deterioration of carrier RNA used in the extraction process, and once that was 
overcome the samples performed as expected in the multiplex tandem assay. There was insufficient 
sample from the remaining four patients to complete similar further investigations. Other samples with 
discrepant results were due to the absence of specific primers and probes to those agents in this tandem 
multiplex real-time assay. They included non-group B adenovirus (9), CMV (3) and non-serogroup b 
Haemophilus influenzae (2). 
The tandem multiplex real-time assay detected respiratory pathogens in 18 specimens for which no 
agent had previously been detected. The agents included RSV (4), rhinovirus (7), human bocavirus (3), 
coronaviruses (3), and parainfluenzavirus. A further 25 specimens had multiple agents detected in the 
tandem multiplex real-time assay compared to the original test result. These additional detections were 
mostly due to the comprehensive range of respiratory pathogens detected by the tandem multiplex 
real-time assay compared to the selective range of tests originally performed as requested by the 
clinician. Positive results were confirmed by repeat testing, and no-template controls were included 
after every fifth sample during the extraction and PCR process to detect contamination events. 
The samples in this study were collected between June and September 2006, which represents mid-
late winter and early spring months, which have typically been the peak respiratory virus detection 
months in the temperate zones of Western Australia. Despite the comprehensive range of agents 
detected by the assay described in this study, 35 (29%) samples still failed to yield a positive result. 
Some of these may be due to suboptimal specimen types for some viruses; poor collection, transport or 
storage conditions; samples collected too late in the time course of infection; or non-infectious causes Viruses 2009, 1  
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of respiratory symptoms. However, it may also indicate possible infection with as yet unknown 
pathogens.  
The significance of the recently described KI and WU polyomaviruses as pathogens remains to be 
established since, although there has been an association with the respiratory tract [24], a recent report 
found no association between polyomavirus infection and respiratory disease [25]. In our study KI and 
WU polyoma viruses were each detected in 4 different samples (3%), but always in combination with 
another virus, including RSV, adenovirus, rhinovirus, bocavirus, coronavirus and parainfluenzavirus. 
The widespread and increasing use of molecular detection techniques has led to reports of multiple 
pathogenic agents detected in single samples [26-28]. This study supports those findings with two 
agents detected in 19 (16%) samples, and three or more agents detected in 10 (8%) samples (Table 2). 
No data was available to determine whether this may have altered the severity of illness. Some studies 
have reported more severe clinical presentation in the presence of mixed infection [9,29,30] while 
others have reported no significant greater disease severity in dual respiratory infection [31]. 
It has been reported that the detection of multiple agents in a multiplex PCR assay was severely 
compromised when the ratio of target materials in the sample exceeded 100:1 [32]. We also found 
similar inhibition in a traditional multiplex which was less evident in the tandem multiplex real-time 
assay (data not shown). In practice, the tandem multiplex real-time assay detected multiple pathogens 
in 29/121 (24%) samples. 
Table 2. Agents detected in PNA samples from 121 hospitalized children.
  
Number of 
samples 
Original reported result† 
Tandem multiplex real-time PCR plus 
supplementary picornavirus and 
metapneumovirus semi-nested PCR result 
12  RSV  RSV A (4), RSV B (8) 
1  RSV, PIV-1  RSV B, PIV-1 
12  Human rhinovirus (HRV)  HRV 
1  HRV, PIV-1  HRV, PIV-1 
4  Influenza virus B  Influenza virus B 
1 PIV-1  PIV-1 
2 PIV-3  PIV-3 
1  Human metapneumovirus   Human metapneumovirus (hMPV) 
31 Neg  Neg 
4  Neg  RSV A (2), RSV B (2) 
7 Neg  HRV 
3 Neg  HBoV 
1  Neg  HRV, KI polyomavirus 
1 Neg  HCoVHKU1 
1 Neg  HCoVNL63,  Pneum jirovecii, WU polyomavirus 
1 Neg  HCoVNL63 
1 Neg  PIV-3 
4  RSV  RSV A, HRV 
1  RSV  RSV B, HRV 
2  RSV  RSV A, HBoV, GAS 
1  RSV  RSV A, HBoV Viruses 2009, 1  
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Table 2. Cont. 
1  RSV  RSV B, HBoV 
2  RSV  RSV A, HRV, KI polyomavirus 
2  RSV  RSV B, HCoVHKU1 
1 HRV  HRV,  HCoVNL63 
1 HRV  HRV,  HBoV 
1 AdV  HRV,  AdV 
1  Influenza virus B  Influenza virus B, HCoVHKU1 
1  RSV, AdV  RSV A, HRV, HBoV, GAS 
1  RSV, AdV  RSV B, HRV, HBoV, GAS 
1  RSV, AdV  RSV B, HRV, HBoV, HCoVNL63 
1  RSV, AdV  RSV A, GAS 
2  RSV, AdV  RSV B 
1  RSV, AdV  RSV A, HRV, KI polyomavirus 
1  RSV, AdV  RSV B, HBoV 
1 RSV,  Haemophilus influenzae RSV  A 
1 AdV  WU  polyomavirus 
1  CMV  HRV, WU polyomavirus 
1 CMV  HRV 
1 CMV  hMPV 
1  Haemophilus influenzae  Neg 
1  RSV, PIV-2  RSV B 
1  RSV, PIV-3  RSV A, HBoV, HCoVHKU1,WU polyomavirus 
1  Influenza virus B  Neg 
2 HRV  Neg 
1 hMPV  Neg 
† Original reported result for tests requested by clinician, performed as nested PCR assays except 
CMV (real-time PCR) and Haemophilus influenzae (bacterial culture). 
2.3. Economies delivered by the tandem multiplex real-time PCR format 
Traditionally, testing for a comprehensive range of respiratory pathogens has necessitated multiple 
PCR assays, immunofluorescence or multiple cell culture assays to be performed on each sample. 
Considerable specimen volume is required to produce sufficient nucleic acid extracts for multiple PCR 
assays and, since many respiratory viruses have an RNA genome, multiple reverse transcription 
reactions are required. Multiple extraction and reverse transcription reactions significantly increase the 
cost of the assays. There have been recent reports of limited multiplex PCR assays [26,33-36] and real-
time multiplex PCR assays for the detection of respiratory viruses and bacteria [37-39]. 
Immunofluorescent antigen detection tests may be used but require a substantial volume of sample, as 
well as needing an adequate cellular content. Cell culture techniques require considerable sample 
volume, a range of different cell lines, and the means for detecting and identifying those agents that are 
successfully cultivated. Many of the recently described novel viruses including human 
metapneumovirus, coronaviruses, human bocavirus and some rhinoviruses are difficult or impossible 
to cultivate in cell cultures [26-28,40,41]. Viruses 2009, 1  
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A multiplex tandem PCR was recently described for gene expression profiling [10]. The first 
enrichment reverse transcription PCR contained up to 72 primer pairs, and the individual second PCR 
assays utilized SYBR Green detection of products. We have modified that technique to include 
specific Taqman probes in the second PCR assay to permit specific real-time detection of the PCR 
product. The two enrichment PCR mixes contain 27 and 7 primer pairs, and the real-time PCR mixes 
contain 1-3 primer pairs with their corresponding fluorophore-labelled probes (Table 3). The 
enrichment PCR was limited to 20 amplification cycles to reduce amplification competition between 
targets, and the dilution of that enrichment PCR product prior to addition to the real-time PCR mix, 
limited non-specific product formation and carry-over primer competition in the secondary PCR   
assay [10]. 
The use of nucleic acid extraction and liquid handling robots streamlined this tandem multiplex 
real-time assay. The nucleic acid extracted from the specimens and controls was eluted into tubes in a 
96-well format. The enrichment PCR and dilutions were all performed in 96-well plates, and robots 
used to transfer diluted enrichment PCR products to the 100-tube discs preloaded with real-time PCR 
reaction mixes (Genedisc-100, Corbett Life Science, Australia). Since the initial cycling step was 
limited to 20 cycles the transfer of those products had a reduced the risk of contamination compared 
with a traditional nested assay. 
The addition of standardized amounts of equine herpesvirus and MS2 RNA coliphage to the digest 
buffer supplied in the nucleic acid extraction kit, served as a control for the DNA and RNA extraction 
process, the removal of inhibitors to the cDNA production and PCR amplification processes, and the 
successful completion of the cDNA procedure. CT values in the specific real-time PCR assays for 
these internal controls were monitored to avoid false-negative reports. 
This tandem multiplex real-time PCR assay, in combination with the semi-nested picornavirus and 
human metapneumovirus PCR assays, tests for 35 respiratory agents from a sample volume of 180µL 
compared to 720 µL required for the individual assays. A single sample extraction and three reverse 
transcription reactions are required for the tandem multiplex real-time assay, compared to four 
extractions and 17 reverse transcription reactions for the individual assays. In our laboratory the 
consumable costs are approximately AUD 67 for the individual assays compared to AUD 17 for the 
tandem multiplex real-time assay. Further work is planned to incorporate the picornavirus and human 
metapneumovirus assays into the tandem multiplex real-time PCR assay, but so far we have been 
unable to design or use published real-time PCR primers and probes that detect all types of these 
viruses with the same sensitivity as our nested assays. 
The multiplex tandem PCR assay described has the potential to test for a much larger number of 
infectious agents, or to look for multiple targets in single agents. In this study, enrichment PCR-B 
contained only seven primer pairs, so it will be possible to add extra primers to detect a broader range 
of known or newly described agents. For example, it is planned to include primers directed against 
adenoviruses other than group B, and a broader range of Haemophilus influenzae serogroups. 
Similarly, continued experience with the assay and further assessment of the role of novel agents in 
respiratory disease, may lead to the removal of some primer pairs from the PCR mixes. 
This test also allows the flexibility to determine which of the organisms included in the enrichment 
PCR are to be included in the second round, usually with the aim of restricting the initial testing to the Viruses 2009, 1  
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most common pathogens. If this is negative, tests for other organisms included in the enrichment PCR 
can then be performed without the need for more sample or further cDNA synthesis.  
3. Materials and Methods 
3.1. Nucleic acid extraction 
Bacterial and viral RNA and DNA was extracted from respiratory specimens including nose swabs, 
throat swabs, pernasal aspirates and sputum samples, using a modified liquid sample protocol with the 
X-tractor Gene instrument (Corbett Life Science, Australia). Standardized doses of equine herpesvirus 
type 4 (EHV4) and MS2 RNA coliphage (MS2) were added to the lysis buffer supplied with the kit to 
monitor the efficiency of sample extraction, removal of reverse transcription and PCR inhibitors, and 
cDNA production [42, 43]. The CT values expected for the EHV4 and MS2 assays were between 15 
and 20, and samples with CT values greater than 27 were retested. 
3.2. Primer and Probe Design 
Taqman primers and probes listed in Table 3, were designed in-house using Primer Express 
software (Applied Biosystems, USA), with the exception of those for the influenza virus A matrix 
gene [44]. The letter in the final column of the table indicates which of the enrichment PCR mixes 
contained the primers, and the number indicates which of the real-time PCR mixes contained the 
primers and probes. At present, not all of the real-time PCR mixes contain uniquely specific 
fluorophore-labelled probes, so further confirmation of some positive results is required. For example, 
in the parainfluenza mixes the types 1 and 2 probes both have FAM labels and the type 4A and 4B 
probes both have VIC labels, so individual real-time PCRs may be performed from the original 
enrichment PCR material if further typing is required. The mixes were prepared in large volumes, 
stored in single use aliquots at -80
°C, and batches were quality tested prior to use. 
Table 3. Primers and probes included in the multiplex tandem real time PCR assay. 
Target (Abbreviation) 
Gene target 
Primer or 
Probe name 
Sequence 5’-3’  Size 
(bp) 
PCR 
mix
a 
Adenovirus (AdV) 
(Group B) 
Hexon gene 
ADB-F 
ADB-R 
ADBProbe1 
ADBProbe2 
GACAGGATGCTTCGGAGTACCT 
TTTCTAAACTTKTTYCCCAYAYTGAA 
6FAM-CACCAGACCCGGACT-MGBNFQ 
6FAM-CTGCACCAGACCCGG-MGBNFQ 
91 A-2 
Bocavirus (HBoV) 
VP1 
BOCA-F 
BOCA-R 
BocaProbe 
TGGGCCATTTAATCCACTTGA 
AATTGAGCAGCGCGATCAG 
VIC-ATTTACAGGTTCACCGTT-MGBNFQ 
63 A-2 
Bordetella species 
Insertion element 
 
B parapertussis & 
B bronchoseptica 
Pertussis toxin 
IS481-F 
IS481-R 
IS481 Probe 
BPA-F 
BPA-R 
BPA Probe 
CGGATGAACACCCATAAGCA 
AACTTGATGGGCGATCAATTG 
6FAM-TCCTACGTCGACTCGAA-MGBNFQ 
ATCCCGCTACTGTAATCCAA 
GGTACCATCGTGCGACTTT 
6FAM-CACGGCGCAAAC-MGBNFQ 
81 
 
 
64 
A-5 
 
 
A-5 
Chlamydophila 
pneumoniae 
MOMP 
CPD-F 
CPD-R 
CPD Probe 
GAAGGGTTCCATGCAGTTAAGTTT 
TGATGCTGATAACATCCGCATT  
VIC-CTCAGCCAAARCTACCTACAGMGBNFQ 
75 A-3 Viruses 2009, 1  
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Table 3. Cont. 
Chlamydophila 
psittaci 
MOMP 
CPSITT-F 
CPSITT-R 
CPsittProbe 
CTCCTTACAAGCCTTGCCTGTAG 
CCCACATAGTGCCATCGATTAA 
CY5.5C+CCAGC+TGAA+C+CAAG+TT-BHQ3 
(LNA) 
68 A-2 
Coronavirus 229E 
(HCoV229E) 
Nucleocapsid 
229E-F 
229E-R 
229E Probe 
CTGCCAAGAGTCTTGCTCGTT 
TCTTTTCCACCGTGGCTTTT 
VIC-AGAACAAAAGCATGAAATG-MGBFQ 
80 A-6 
Coronavirus HKU1 
(HCoVHKU1) 
ORF 1a/b 
HKCOR-F 
HKCOR-R 
HKCoProbe 
CCCGCAAACATGAATTTTGTT 
CATTCATTCGCAAGGCGATA 
6FAM-AATCTATCACCATGTGAA-MGBNFQ 
61 A-7 
Coronavirus NL63 
(HCoVNL63) 
Nucleocapsid 
NL63-F 
NL63-R 
NL63 Probe 
AACCTCGTTGGAAGCGTGTT 
CGAGGACCAAAGCACTGAATAA 
VIC-ATTTTCCTCTCTGGTAG-MGBNFQ 
61 A-7 
Coronavirus OC43 
(HCoVOC43) 
Nucleocapsid 
OC43-F 
OC43-R 
OC43 Probe 
GACATGGCTGATCAAATTGCTAGT 
GCTGAGGTTTAGTGGCATCCTT 
6FAM-TCTGGCAAAACTTGG-MGBNFQ 
67 A-6 
Equine herpesvirus 4 
(EHV) 
Glycoprotein gB 
EHV-F 
EHV-R 
EHV Probe 
GATGACACTAGCGACTTCGA 
CAGGGCAGAAACCATAGACA 
6FAM-TTTCGCGTGCCTCCTCCAG-BHQ1 
81 B-17 
Haemophilus 
influenzae  Serotype b 
capsulation locus 
HINF-F 
HINF-R 
HINF Probe 
AGAAGTTTTACTGATGATATGGGTACATCT 
GCTCGAAGAATGAGAAGTTTTGTG 
6FAM-TTCGCCATAACTTCATCT-MGBNFQ 
79 B-14 
Influenza virus A  
Matrix
 
[44] 
FA-MATF 
FA-MATR 
FA Probe 
CTTCTAACCGAGGTCGAAACGTA 
GGTGACAGGATTGGTCTTGTCTTTA 
CALOTCAGGCCCCCTCAAAGCCGAGBHQ1 
155 A-4 
Influenza virus A H3 
haemagglutinin 
H3N2-F 
H3N2-R 
H3HAProbe 
ACGAAGTGGGAAAAGCTCAATAAT 
GGAGTGATGCATTCAGAATTGC 
6FAM-ATGCACCCATTGGC-MGBNFQ 
72 A-11 
Influenza virus A H1 
haemagglutinin 
H1N1-F 
H1N1-R 
H1HAProbe 
AAGCTCATGGCCCAACCA 
CCATTATGGGAGCATGATGCT 
6FAM-ATACTCCGGTCACGGT-MGBNFQ 
57 A-12 
Influenza virus B 
matrix 
FBMAT-F 
FBMAT-R 
FB Probe 
TGCCTACCTGCTTTMMYTRACA 
CCRAACCAACARTGTAATTTTTCTG 
6FAM-TGCTTTGCCTTCTCCA-MGBNFQ 
75 A-4 
Influenza virus C 
NS1 
FLUC-F 
FLUC-R 
FLUCProbe 
CCTAGAACITGGGAAGAKGCR 
GCAGAATCGTYCCGTTGAA 
6FAM-AGRAGCTCACMAYCTTTT-MGBNFQ 
61 A-4 
Legionella 
longbeachae 
mip gene 
LLong-F 
LLong-R 
LLongProbe 
TGGTCACTGCGGCCATTA 
CATCAGTTGCAGCCATTGCT 
6FAM-ACATTGCCAAACCCA-MGBNFQ 
58 A-3 
Legionella 
pneumophila 
mip gene 
LPN-F 
LPN-R 
LPN Probe 
CAATGGCTAAAGGCATGCAA 
TGCTGTTCGGTTAAAGCCAAT 
6FAM-AGCGCCACTCATAGCGT-MGBNFQ 
61 A-3 
Moraxella 
catarrhalis 
OMP 
MOR-F 
MOR-R 
MOR Probe 
TCGCCAAGGTGCRAAAATTAA 
GCCGTGCTTTCGTCTTTTTC 
VIC-ACCAATGTTGTTACCTTRCG-MGBNFQ 
63 B-14 
MS-2 RNA 
coliphage 
Coat protein 
MS2-F 
MS2-R 
MS2 Probe 
GTCGACAATGGCGGAACTG 
TTCAGCGACCCCGTTAGC 
CALOACGTGACTGTCGCCCCAAGCAACTT-BHQ1 
66/ 
74 
A-1 
Mycoplasma 
pneumoniae 
Cytadhesion P1 
MPN-F 
MPN-R 
MPN Probe 
AAGTACCACCACGACGCTCAA 
TCGTCAGGGCGGGTGTAG 
6FAM–CGCCAGCAATTTA–MGBNFQ 
54 A-10 Viruses 2009, 1  
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Parainfluenzavirus 
(PIV) 
Nucleoprotein 
PF1-F 
PF1-R 
PF1 Probe 
PF2-F 
PF2-R 
PF2 Probe 
PF3-F 
PF3-R 
PF3 Probe 
PF4A-F 
PF4A-R 
PF4A Probe 
PF4B-F 
PF4B-R 
PF4B Probe 
GCAAAGAGARAATGCRGATCTAG 
AGCTCCGAGACATGCAGGAT 
6FAMTCCATATGTCTGAAGCAATMGBNFQ 
ATTCCAGATGCTCGATCAACTATG 
TCYTCAGCTAATGCTTCRAARGC 
6FAM-AGCACYTCTCCTCTGG-MGBNFQ 
CGCGCTCCWTTYATCTGTATC 
TTGCCTGGTGCGAACTCA 
VIC-TCAGAGATCCYATACATG-MGBNFQ 
CACACACACAATGGGCACAA 
GCGTATTTGGTGAGAGTTTTGAGTT 
VIC-CAATCCCACACTACAAC-MGBNFQ 
CGCACACATACAATGAAAGCAA 
TGGCGGGATTTCTGAGTTG 
VIC-CACTCCTGTCCCACATC-MGBNFQ 
67 
 
 
65 
 
 
59 
 
 
65 
 
 
60 
A-8 
 
 
A-8 
 
 
A-8 
 
 
A-9 
 
 
A-9 
Pneumocyctis 
jirovecii 
5S rRNA 
PN-F 
PN-R 
PN Probe 
CCATACCTCAGAGAATATACCGTATCC 
TACTGACGACGCCCTTCAGA 
6FAM–TRACTTCGCAGATCG–MGBNFQ  
69 A-10 
Polyomavirus  
VP1 
KI-F 
KI-R 
KI Probe 
 
WU-F 
WU-R 
WU Probe 
GGTTCTGGAGCTGCCATAGC 
AAGAAGTGCAGCTCCCTCTGTT 
6FAM-CCAAGGGCAGCTAAGCCTTCACCA-BHQ1 
AGTCAACCCACAAGAGTGCAAA 
CAGCACGTCTACCCCTCCTTT 
VIC-CCTTCCAAAACAAGTCAG-MGBNFQ 
77 
 
 
 
63 
B-16 
 
 
 
B-16 
Respiratory syncytial 
virus A (RSV A) 
Nucleoprotein 
Respiratory syncytial 
virus B (RSV B) 
Nucleoprotein 
RSVA-F 
RSVA-R 
RSVAProbe 
RSVB-F 
RSVB-R 
RSVBProbe 
CAACTTCTGTCATCCAGCAAA  
TGCACATCATAATTAGGAGTATCAAT 
6FAM-CACCATCCAACGGAGC-MGBNFQ  
ATTCAACGTAGTACAGGAGATAATA 
CCACATAGTTTGTTTAGGTGTTT 
VIC-TGACACTCCCAATTAT-MGBNFQ  
77 
 
 
74 
A-9 
 
 
A-5 
Group A 
Streptococcus 
speB gene 
STAspeB-F 
STAspeB-R 
STspBProbe 
CTAAACCCTTCAGCTCTTGGTACTG 
TTGATGCCTACAACAGCACTTTG 
6FAM-CGGCGCAGGCGGCTTCAAC-BHQ1 
77 B-11 
Streptococcus 
pneumoniae 
Pneumolysin gene 
Pneum-F 
Pneum-R 
Pn Probe 
CCACTCTTCTTGCGGTTGATC 
GCCAAACCAGGCAAATCAAT 
6FAM-TGCTCCGATGACTTATA-MGBNFQ 
61 B-14 
a The letter indicates in which of the two enrichment PCR assays the primers are included, and the 
number indicates in which of 16 real time PCR mixes the primers and corresponding probes may be 
found. 
3.3. PCR 
Enrichment PCR assays A & B, were set up in 96-well plates (Axygen Scientific, USA) using a 
liquid handling robot (CAS1200 Corbett Life Science, Australia) to add PCR reaction mix and the 
sample or control nucleic acid extracts. The first enrichment PCR used the Superscript III Platinum 
One-step RT-PCR system (Invitrogen, USA). The 50µL reaction mix A contained 54 primers each at 
0.2-0.3µM, 10 units RNaseOUT (Invitrogen, USA), 10mM DTT (Sigma, USA), 0.75µL Superscript 
III RT/Platinum Taq Mix, 1.25unit iStar Taq DNA polymerase (Intron Biotechnology, USA), 1.5% 
DMSO (Sigma, USA), and 8 µL RNA/DNA specimen extract. The cycling conditions were 30 min at Viruses 2009, 1  
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50 
°C, 5 min at 95 
°C, followed by 20 cycles of 94 
° C for 30 sec, 50 
°C for 30 sec, and 68 
°C for 45 sec, 
on an ABI 2700 thermal cycler (Applied Biosystems, USA). The 50 µL reaction mix B contained 14 
primers each at 0.2 µM, 4 mM MgCl2 (Applied Biosystems, USA), 200 µM dNTP (Fisher Biotec, 
Australia), 0.01% bovine serum albumin (Sigma, USA), 1.5 units Amplitaq Gold DNA polymerase 
(Applied Biosystems, USA) and 8µL RNA/DNA specimen extract. Cycling conditions were 95
°C for 
10 min, followed by 20 cycles of 95
°C for 30 sec, 50
°C for 30 sec and 72
°C for 45 sec. 
The initial enrichment PCR products were diluted 1:10 in PCR grade water, and a 1.0 µL sample 
was added to a 20 µL reaction mix in 100 tube rings (Gendisc-100, Corbett Life Science, Australia) 
containing 2-6 oligonucleotide primers at 0.2 µM, 0.2 µM Taqman probes, 6 mM MgCl2, 0.4 mM 
dNTP, and 1.0 unit of i-StarTaq DNA polymerase. The dilution and product transfer procedures were 
performed by a liquid handling robot (CAS1200 Corbett Life Science, Australia). The reaction was 
cycled on a Rotorgene 6000 real time thermocycler (Corbett Life Science, Australia). The cycling 
conditions were 94 
°C for 2 min, followed by 35 cycles of 94 
°C for 12 sec, 55 
°C for 90 sec and 72 
°C 
for 20 sec. Probe emission signals were acquired during the 20 sec extension step of the cycling 
programme. The relatively long 90 second annealing step was found to improve the sensitivity of the 
multiple primer and probe real-time PCR assay (data not shown).  
The singleplex real-time PCR assays used in the sensitivity comparison with the tandem multiplex 
real-time assays were performed as for the enrichment PCR assays described above, except that the 
only a single primer pair and the appropriate fluorophore-labelled oligonucleotide probe (0.2 µM) 
were included in the PCR reaction mix. The number of cycles was increased to 50, the denaturation, 
annealing and extension steps were reduced to 10, 15 and 15 secs, respectively, and performed on the 
Corbett RG6000 thermocycler (Corbett Life Science, Australia). 
The nested PCR assays used in the sensitivity comparison assays are mostly “in-house-modified” 
assays and have been used in our diagnostic laboratory for many years. Since they are slowly being 
superseded by real-time amplification assays, the primer sequences have not been listed in this article 
but are available on application to the authors. Briefly, the nested assays used 8µL of nucleic acid 
sample in a 20 µL reaction volume in the Superscript III Platinum One-step RT-PCR (Invitrogen, 
USA) or the Amplitaq Gold DNA polymerase  system (Applied Biosystems, USA).  Appropriate 
enzyme activation was followed by 45 cycles of 95 
°C for 30 sec, 50 
°C for 30sec and 72 
°C for 45 sec. 
Similar conditions were used for the second PCR assay with 0.5 µL of the initial PCR product as the 
target DNA. Amplicons were detected by ethidium bromide agarose gel electrophoresis. 
The picornavirus and human metapneumoviruses were detected using traditional semi-nested PCR 
assays as we have not yet been able to design real-time PCR assays to reliably detect all strains of 
those viruses. The picornavirus PCR utilized published primer sets targeting the 5’ untranslated region 
of the virus genome [45, 46] and enterovirus or rhinovirus identification was confirmed by DNA 
sequencing. The in-house human metapneumovirus assay targets the matrix protein gene of the virus.  
Well characterized DNA and RNA control materials were tested in traditional nested PCR assays, 
individual real-time assays and in the multiplex tandem real-time PCR assay. 
A collection of 121 respiratory samples from hospitalized children was tested in the multiplex 
tandem real-time assay. The samples were received at the PathWest Laboratory Medicine WA facility 
for the routine investigation of respiratory infection and had previously been tested for a narrow range 
of respiratory pathogens. Samples had been stored at -20
°C. Viruses 2009, 1  
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No-template controls were included in the extraction process between every five samples and 
treated as samples for the completion of the assays. Since all PCR mixes were quality checked for all 
agents prior to use, and the internal controls cover the extraction, inhibitor removal and cDNA 
production processes, specific positive control materials were only included in the real-time Taqman 
PCR assays. Those control materials were well-characterized enrichment PCR products stored in 
aliquots at -20 °C. 
4. Conclusions 
A tandem multiplex real-time assay is presented which detects a comprehensive range of respiratory 
pathogens from a specimen sample of 180µL. The initial enrichment PCR eliminates the requirement 
for individual reverse transcription steps for each of the RNA viruses, resulting in considerable cost 
and specimen volume benefits. The secondary multiplex real-time PCR utilizes probes labeled with 
different fluorophores to facilitate a rapid result. 
The technique may be used in the routine diagnostic setting or in an outbreak or pandemic situation, 
to facilitate testing for a range of common, exotic and emerging pathogens. Extra primers and probes 
for novel agents may be easily accommodated in this technique. 
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